US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

IDEAYA Biosciences

39.95

-0.1500-0.37%

Post-market: 39.950.00000.00%19:30 EDT

Volume:587.80K

Turnover:23.31M

Market Cap:3.85B

PE:-20.42

High:40.20

Open:39.85

Low:38.90

Close:40.10

52wk High:42.68

52wk Low:23.23

Shares:96.27M

Float Shares:94.37M

Volume Ratio:0.74

T/O Rate:0.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9561

EPS(LYR):-1.2849

ROE:-16.22%

ROA:-11.54%

PB:3.21

PE(LYR):-31.09

Loading ...

Overview Company News Filings

Ideaya Biosciences, Servier announce topline results from OptimUM-02 trial

U.S. Stocks to Watch: Goldman Sachs, SanDisk, Exxon Mobil, Nvidia, Ideaya, and More

Tiger Newspress

Ideaya eye cancer drug meets main goal of mid-to-late-stage trial

IDEAYA says darovasertib-crizotinib trial cuts progression risk 58% in metastatic uveal melanoma

IDEAYA Biosciences Shares Gain 18% Premarket Ahead of Data Release for Its Experimental Cancer Drug

THOMSON REUTERS

IDEAYA Biosciences Inc - Trial Met Primary Endpoint Showing Statistically Significant Improvement in Median Pfs by Bicr

THOMSON REUTERS

IDEAYA Biosciences Inc - Nda Submission Planned for Second Half of 2026 to Support U.S. Accelerated Approval

THOMSON REUTERS

IDEAYA Biosciences and Servier Announce Positive Topline Results From Phase 2/3 Registrational Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla-a*02:01-Negative Metastatic Uveal Melanoma

THOMSON REUTERS

Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)

Ideaya Biosciences Shares Gain Ahead of Trial Results

BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026

IDEAYA to report topline OptimUM-02 darovasertib-crizotinib trial results April 13

IDEAYA Biosciences to Announce Topline Results From Phase 2/3 Optimum-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman

Ideaya Biosciences Inc - Enters Clinical Collaboration Agreement With Astrazeneca On April 8, 2026 - SEC Filing

IDEAYA, AstraZeneca partner to test IDE849 with Imfinzi in small cell lung cancer

IDEAYA Biosciences Inc - Co to Sponsor Study; AstraZeneca to Supply Imfinzi - SEC Filing

THOMSON REUTERS

IDEAYA Biosciences Inc - Agreement to Evaluate Ide849 With Imfinzi in Extensive-Stage Small Cell Lung Cancer - SEC Filing

THOMSON REUTERS

IDEAYA Biosciences Inc - Advancing Global Phase 1 Trial for Ide849 in Dll3 Upregulated Solid Tumors - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IDYA/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IDYA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":39.95,"timestamp":1788292800000,"preClose":40.1,"halted":0,"volume":587802,"hourTrading":{"tag":"盘后","latestPrice":39.95,"preClose":39.95,"latestTime":"19:30 EDT","volume":17437,"amount":696608.01,"timestamp":1788305405758,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0037406483790523334,"floatShares":94374456,"shares":96274800,"eps":-1.956123,"marketStatus":"Not Yet Opened","change":-0.15,"latestTime":"09-01 16:00:00 EDT","open":39.85,"high":40.2,"low":38.9,"amount":23307078.174480002,"amplitude":0.032419,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.956123,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788336000000},"marketStatusCode":0,"adr":0,"listingDate":1558584000000,"exchange":"NASDAQ","adjPreClose":40.1,"preHourTrading":{"tag":"盘前","latestPrice":39.62,"preClose":40.1,"latestTime":"09:25 EDT","volume":10412,"amount":417364.29116,"timestamp":1788269100040,"change":-0.48,"changeRate":-0.01197,"amplitude":0.014214},"postHourTrading":{"tag":"盘后","latestPrice":39.95,"preClose":39.95,"latestTime":"19:30 EDT","volume":17437,"amount":696608.01,"timestamp":1788305405758,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.739672,"impliedVol":0.7475,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDYA\",,,,,undefined,":{"symbol":"IDYA","floatShares":94374456,"roa":"-11.54%","roe":"-16.22%","lyrEps":-1.284937,"volumeRatio":0.739672,"shares":96274800,"dividePrice":0,"high":40.2,"amplitude":0.032419,"preClose":40.1,"low":38.9,"week52Low":23.23,"pbRate":"3.21","psRate":"16.43","week52High":42.68,"institutionHeld":0,"latestPrice":39.95,"eps":-1.956123,"divideRate":0,"volume":587802,"delay":0,"ttmEps":-1.956123,"open":39.85,"prevYearClose":34.57,"prevWeekClose":40.11,"prevMonthClose":40.1,"prevQuarterClose":37.27,"fiveDayClose":42.48,"twentyDayClose":36.11,"sixtyDayClose":28.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDYA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"IDYA","fiscalQuarterEnding":"2026/06","expectedEps":-1.18,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-1.22},{"market":"US","date":"2026-05-05","symbol":"IDYA","fiscalQuarterEnding":"2026/03","expectedEps":-1.07,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-1.11},{"date":"2026-02-17","symbol":"IDYA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771318800000,"name":null,"time":"Pre-MKt","dateTimestamp":1771304400000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"IDYA","fiscalQuarterEnding":"2025/09","expectedEps":0,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":1.33},{"market":"US","date":"2025-08-05","symbol":"IDYA","fiscalQuarterEnding":"2025/06","expectedEps":-0.85,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDYA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDYA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3125,"buy":0.625,"hold":0.0625,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":16,"updateTime":1764216000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IDYA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IDYA","date":"2026-08-31","current":-20.438388,"percent":0.245928,"low":-34.624829,"twenty":-23.659867,"median":-17.608694,"eighty":-8.451147,"high":-4.624403,"avg":-16.915809,"sd":7.528501,"marketCap":3870193203},"quantilePoints":[{"date":"2021-09-03","current":-31.722379,"twenty":-16.958969,"median":-7.318795,"eighty":-3.549073,"marketCap":952591312},{"date":"2021-09-10","current":-33.985523,"twenty":-17.480455,"median":-7.331359,"eighty":-3.549073,"marketCap":1020551273},{"date":"2021-09-17","current":-34.343535,"twenty":-18.002071,"median":-7.384758,"eighty":-3.550496,"marketCap":1031302001},{"date":"2021-09-24","current":-32.451188,"twenty":-18.564804,"median":-7.425593,"eighty":-3.554316,"marketCap":974476724},{"date":"2021-10-01","current":-32.655766,"twenty":-19.003246,"median":-7.482701,"eighty":-3.556676,"marketCap":980619997},{"date":"2021-10-08","current":-32.70691,"twenty":-19.603951,"median":-7.576366,"eighty":-3.556676,"marketCap":982155815},{"date":"2021-10-15","current":-29.57431,"twenty":-19.948284,"median":-7.607522,"eighty":-3.556676,"marketCap":888086943},{"date":"2021-10-22","current":-29.305801,"twenty":-20.299726,"median":-7.64547,"eighty":-3.561126,"marketCap":880023897},{"date":"2021-10-29","current":-27.413454,"twenty":-20.498333,"median":-7.666222,"eighty":-3.5648,"marketCap":823198619},{"date":"2021-11-05","current":-30.149685,"twenty":-20.989624,"median":-7.758551,"eighty":-3.569714,"marketCap":905364899},{"date":"2021-11-12","current":-29.446448,"twenty":-21.062795,"median":-7.793103,"eighty":-3.570043,"marketCap":884247397},{"date":"2021-11-19","current":-24.362497,"twenty":-21.240496,"median":-7.827655,"eighty":-3.571919,"marketCap":893738217},{"date":"2021-11-26","current":-24.981527,"twenty":-21.39159,"median":-7.890477,"eighty":-3.574612,"marketCap":916447328},{"date":"2021-12-03","current":-23.145422,"twenty":-21.857223,"median":-7.96045,"eighty":-3.584136,"marketCap":849089797},{"date":"2021-12-10","current":-22.914597,"twenty":-22.068374,"median":-8.022404,"eighty":-3.586999,"marketCap":840621993},{"date":"2021-12-17","current":-22.841153,"twenty":-22.307678,"median":-8.080851,"eighty":-3.590242,"marketCap":837927691},{"date":"2021-12-23","current":-24.519878,"twenty":-22.478131,"median":-8.112599,"eighty":-3.600896,"marketCap":899511720},{"date":"2021-12-31","current":-24.803163,"twenty":-22.661484,"median":-8.124771,"eighty":-3.607486,"marketCap":909904025},{"date":"2022-01-07","current":-18.854181,"twenty":-22.696715,"median":-8.133171,"eighty":-3.607884,"marketCap":691665623},{"date":"2022-01-14","current":-18.6968,"twenty":-22.661484,"median":-8.166895,"eighty":-3.6108,"marketCap":685892120},{"date":"2022-01-21","current":-16.01084,"twenty":-22.62885,"median":-8.217153,"eighty":-3.61443,"marketCap":587357674},{"date":"2022-01-28","current":-16.304617,"twenty":-22.589226,"median":-8.232117,"eighty":-3.61955,"marketCap":598134879},{"date":"2022-02-04","current":-16.336093,"twenty":-22.528306,"median":-8.279975,"eighty":-3.626979,"marketCap":599289580},{"date":"2022-02-11","current":-15.95838,"twenty":-22.480222,"median":-8.317669,"eighty":-3.641021,"marketCap":585433173},{"date":"2022-02-18","current":-14.290147,"twenty":-22.452959,"median":-8.349952,"eighty":-3.663377,"marketCap":524234045},{"date":"2022-02-25","current":-14.300639,"twenty":-22.416661,"median":-8.361644,"eighty":-3.680345,"marketCap":524618945},{"date":"2022-03-04","current":-12.663882,"twenty":-22.374982,"median":-8.467308,"eighty":-3.689682,"marketCap":464574517},{"date":"2022-03-11","current":-13.4298,"twenty":-22.27281,"median":-8.578381,"eighty":-3.700816,"marketCap":492672230},{"date":"2022-03-18","current":-9.803903,"twenty":-22.210534,"median":-8.63295,"eighty":-3.710538,"marketCap":487861813},{"date":"2022-03-25","current":-8.880178,"twenty":-22.137363,"median":-8.648165,"eighty":-3.728362,"marketCap":441895419},{"date":"2022-04-01","current":-8.849128,"twenty":-22.038758,"median":-8.676953,"eighty":-3.732947,"marketCap":440350330},{"date":"2022-04-08","current":-8.771505,"twenty":-22.005987,"median":-8.686118,"eighty":-3.735526,"marketCap":436487608},{"date":"2022-04-14","current":-8.39891,"twenty":-21.980806,"median":-8.678356,"eighty":-3.739591,"marketCap":417946542},{"date":"2022-04-22","current":-8.297999,"twenty":-21.967416,"median":-8.654251,"eighty":-3.742674,"marketCap":412925003},{"date":"2022-04-29","current":-7.445176,"twenty":-21.940847,"median":-8.644345,"eighty":-3.747479,"marketCap":370486844},{"date":"2022-05-06","current":-7.080292,"twenty":-21.836317,"median":-8.631683,"eighty":-3.752283,"marketCap":352329512},{"date":"2022-05-13","current":-7.388684,"twenty":-21.606351,"median":-8.578381,"eighty":-3.771501,"marketCap":404559983},{"date":"2022-05-20","current":-7.762705,"twenty":-21.554086,"median":-8.467308,"eighty":-3.779737,"marketCap":425039142},{"date":"2022-05-27","current":-7.621565,"twenty":-21.406546,"median":-8.392554,"eighty":-3.780239,"marketCap":417311157},{"date":"2022-06-03","current":-8.397835,"twenty":-21.39159,"median":-8.36786,"eighty":-3.788369,"marketCap":459815071},{"date":"2022-06-10","current":-8.037928,"twenty":-21.387041,"median":-8.380207,"eighty":-3.794466,"marketCap":440108711},{"date":"2022-06-17","current":-8.729514,"twenty":-21.336664,"median":-8.392554,"eighty":-3.799547,"marketCap":477975835},{"date":"2022-06-24","current":-9.795122,"twenty":-21.273946,"median":-8.39891,"eighty":-3.80666,"marketCap":536322117},{"date":"2022-07-01","current":-10.10563,"twenty":-21.225131,"median":-8.471248,"eighty":-3.810725,"marketCap":553323683},{"date":"2022-07-08","current":-10.888958,"twenty":-21.198073,"median":-8.557964,"eighty":-3.815416,"marketCap":596213996},{"date":"2022-07-15","current":-10.938357,"twenty":-21.154154,"median":-8.623821,"eighty":-3.823859,"marketCap":598918791},{"date":"2022-07-22","current":-10.50788,"twenty":-21.113328,"median":-8.640812,"eighty":-3.827243,"marketCap":575348438},{"date":"2022-07-29","current":-10.529051,"twenty":-21.08161,"median":-8.648165,"eighty":-3.852269,"marketCap":576507636},{"date":"2022-08-05","current":-11.107725,"twenty":-21.062795,"median":-8.674304,"eighty":-3.89073,"marketCap":608192372},{"date":"2022-08-12","current":-11.044212,"twenty":-21.057369,"median":-8.686118,"eighty":-3.902788,"marketCap":604714779},{"date":"2022-08-19","current":-6.087169,"twenty":-21.027635,"median":-8.674304,"eighty":-3.912344,"marketCap":400919180},{"date":"2022-08-26","current":-5.735068,"twenty":-20.992994,"median":-8.648165,"eighty":-3.917696,"marketCap":377728757},{"date":"2022-09-02","current":-5.597808,"twenty":-20.953825,"median":-8.640812,"eighty":-3.930533,"marketCap":368688422},{"date":"2022-09-09","current":-5.520226,"twenty":-20.872033,"median":-8.630797,"eighty":-3.94283,"marketCap":363578668},{"date":"2022-09-16","current":-7.849101,"twenty":-20.73156,"median":-8.578381,"eighty":-3.96417,"marketCap":516965327},{"date":"2022-09-23","current":-8.510226,"twenty":-20.611725,"median":-8.513329,"eighty":-3.972574,"marketCap":560509001},{"date":"2022-09-30","current":-10.493601,"twenty":-20.565232,"median":-8.578381,"eighty":-3.993719,"marketCap":691140025},{"date":"2022-10-07","current":-10.198204,"twenty":-20.477427,"median":-8.630797,"eighty":-4.008882,"marketCap":671684341},{"date":"2022-10-14","current":-10.950762,"twenty":-20.387531,"median":-8.642079,"eighty":-4.009677,"marketCap":721250013},{"date":"2022-10-21","current":-11.562654,"twenty":-20.357199,"median":-8.654251,"eighty":-4.014693,"marketCap":761551073},{"date":"2022-10-28","current":-11.956516,"twenty":-20.32892,"median":-8.675551,"eighty":-4.030286,"marketCap":787491986},{"date":"2022-11-04","current":-12.005748,"twenty":-20.283001,"median":-8.686118,"eighty":-4.065307,"marketCap":790734600},{"date":"2022-11-11","current":-15.768029,"twenty":-20.180562,"median":-8.713449,"eighty":-4.079563,"marketCap":830439027},{"date":"2022-11-18","current":-16.115182,"twenty":-20.035419,"median":-8.773737,"eighty":-4.104617,"marketCap":848722157},{"date":"2022-11-25","current":-16.060368,"twenty":-20.023491,"median":-8.779267,"eighty":-4.104763,"marketCap":845835347},{"date":"2022-12-02","current":-16.425792,"twenty":-19.948284,"median":-8.800314,"eighty":-4.104763,"marketCap":865080747},{"date":"2022-12-09","current":-15.384334,"twenty":-19.937676,"median":-8.842235,"eighty":-4.115583,"marketCap":810231356},{"date":"2022-12-16","current":-15.39347,"twenty":-19.766046,"median":-8.880178,"eighty":-4.122926,"marketCap":810712491},{"date":"2022-12-23","current":-15.548775,"twenty":-19.620281,"median":-8.920409,"eighty":-4.130826,"marketCap":818891787},{"date":"2022-12-30","current":-16.599368,"twenty":-19.607217,"median":-8.936255,"eighty":-4.130945,"marketCap":874222313},{"date":"2023-01-06","current":-15.777165,"twenty":-19.59823,"median":-8.94733,"eighty":-4.146129,"marketCap":830920162},{"date":"2023-01-13","current":-17.101825,"twenty":-19.554345,"median":-9.043188,"eighty":-4.162328,"marketCap":900684738},{"date":"2023-01-20","current":-16.106046,"twenty":-19.478065,"median":-9.066475,"eighty":-4.171098,"marketCap":848241022},{"date":"2023-01-27","current":-15.420877,"twenty":-19.243528,"median":-9.155743,"eighty":-4.18158,"marketCap":812155896},{"date":"2023-02-03","current":-16.042097,"twenty":-18.988351,"median":-9.163635,"eighty":-4.19168,"marketCap":844873077},{"date":"2023-02-10","current":-16.416656,"twenty":-18.921278,"median":-9.21308,"eighty":-4.201222,"marketCap":864599612},{"date":"2023-02-17","current":-16.16086,"twenty":-18.818457,"median":-9.237619,"eighty":-4.208561,"marketCap":851127832},{"date":"2023-02-24","current":-15.567046,"twenty":-18.755454,"median":-9.279961,"eighty":-4.218427,"marketCap":819854057},{"date":"2023-03-03","current":-15.7863,"twenty":-18.713587,"median":-9.288903,"eighty":-4.239786,"marketCap":831401297},{"date":"2023-03-10","current":-12.695923,"twenty":-18.685623,"median":-9.337354,"eighty":-4.268913,"marketCap":744679346},{"date":"2023-03-17","current":-12.365944,"twenty":-18.625694,"median":-9.47488,"eighty":-4.277714,"marketCap":725324457},{"date":"2023-03-24","current":-11.450254,"twenty":-18.520909,"median":-9.51831,"eighty":-4.30099,"marketCap":671614641},{"date":"2023-03-31","current":-11.326512,"twenty":-18.333889,"median":-9.637448,"eighty":-4.31253,"marketCap":664356558},{"date":"2023-04-06","current":-11.343011,"twenty":-18.288121,"median":-9.673933,"eighty":-4.318821,"marketCap":665324302},{"date":"2023-04-14","current":-11.433755,"twenty":-18.224659,"median":-9.699267,"eighty":-4.318821,"marketCap":670646896},{"date":"2023-04-21","current":-12.012005,"twenty":-18.140723,"median":-9.745723,"eighty":-4.318821,"marketCap":704564136},{"date":"2023-04-28","current":-17.665967,"twenty":-18.140723,"median":-9.757173,"eighty":-4.324014,"marketCap":1036197283},{"date":"2023-05-05","current":-18.5444,"twenty":-18.345331,"median":-9.795122,"eighty":-4.333623,"marketCap":1087721785},{"date":"2023-05-12","current":-17.975574,"twenty":-18.548481,"median":-9.809491,"eighty":-4.342105,"marketCap":1227408161},{"date":"2023-05-19","current":-17.7789,"twenty":-18.385145,"median":-9.923908,"eighty":-4.345574,"marketCap":1213978850},{"date":"2023-05-26","current":-18.14807,"twenty":-18.548481,"median":-10.050322,"eighty":-4.359142,"marketCap":1239186528},{"date":"2023-06-02","current":-20.069433,"twenty":-18.624,"median":-10.097881,"eighty":-4.366759,"marketCap":1370381033},{"date":"2023-06-09","current":-21.42026,"twenty":-18.679679,"median":-10.133562,"eighty":-4.369631,"marketCap":1462618218},{"date":"2023-06-16","current":-20.925237,"twenty":-18.866911,"median":-10.16981,"eighty":-4.375728,"marketCap":1428817014},{"date":"2023-06-23","current":-21.134993,"twenty":-18.937913,"median":-10.21543,"eighty":-4.380543,"marketCap":1443139558},{"date":"2023-06-30","current":-19.937075,"twenty":-19.13128,"median":-10.25893,"eighty":-4.382308,"marketCap":1361343322},{"date":"2023-07-07","current":-19.327719,"twenty":-19.403716,"median":-10.300042,"eighty":-4.384874,"marketCap":1319735326},{"date":"2023-07-14","current":-19.516534,"twenty":-19.527631,"median":-10.366739,"eighty":-4.396081,"marketCap":1332627944},{"date":"2023-07-21","current":-18.778441,"twenty":-19.516534,"median":-10.433806,"eighty":-4.40569,"marketCap":1282229526},{"date":"2023-07-28","current":-18.083261,"twenty":-19.456456,"median":-10.472595,"eighty":-4.425522,"marketCap":1234761248},{"date":"2023-08-04","current":-18.684034,"twenty":-19.430709,"median":-10.508916,"eighty":-4.445846,"marketCap":1275783217},{"date":"2023-08-11","current":-19.793943,"twenty":-19.456456,"median":-10.529051,"eighty":-4.466169,"marketCap":1467760467},{"date":"2023-08-18","current":-19.297154,"twenty":-19.516534,"median":-10.56417,"eighty":-4.47125,"marketCap":1430922557},{"date":"2023-08-25","current":-21.788862,"twenty":-19.594416,"median":-10.725698,"eighty":-4.489816,"marketCap":1615687698},{"date":"2023-09-01","current":-22.790203,"twenty":-19.620281,"median":-10.783103,"eighty":-4.508424,"marketCap":1689939110},{"date":"2023-09-08","current":-21.773337,"twenty":-19.662379,"median":-10.81952,"eighty":-4.516812,"marketCap":1614536513},{"date":"2023-09-15","current":-22.891113,"twenty":-19.937195,"median":-10.874844,"eighty":-4.541754,"marketCap":1697421810},{"date":"2023-09-22","current":-21.88201,"twenty":-20.044607,"median":-10.927771,"eighty":-4.55153,"marketCap":1622594806},{"date":"2023-09-29","current":-20.640037,"twenty":-20.232827,"median":-10.973642,"eighty":-4.576935,"marketCap":1530500032},{"date":"2023-10-06","current":-20.546889,"twenty":-20.307025,"median":-10.998264,"eighty":-4.587214,"marketCap":1523592923},{"date":"2023-10-13","current":-21.191163,"twenty":-20.399581,"median":-11.044212,"eighty":-4.596272,"marketCap":1571367088},{"date":"2023-10-20","current":-20.127723,"twenty":-20.430908,"median":-11.063294,"eighty":-4.598275,"marketCap":1492510937},{"date":"2023-10-27","current":-22.829497,"twenty":-20.455558,"median":-11.08551,"eighty":-4.599291,"marketCap":1692852872},{"date":"2023-11-03","current":-25.350703,"twenty":-20.512907,"median":-11.133626,"eighty":-4.606404,"marketCap":1879805335},{"date":"2023-11-10","current":-18.349717,"twenty":-20.534125,"median":-11.159417,"eighty":-4.623679,"marketCap":1893819287},{"date":"2023-11-17","current":-18.699474,"twenty":-20.512907,"median":-11.219301,"eighty":-4.647268,"marketCap":1929916591},{"date":"2023-11-24","current":-19.986078,"twenty":-20.508077,"median":-11.235768,"eighty":-4.660326,"marketCap":2062703104},{"date":"2023-12-01","current":-19.642567,"twenty":-20.498333,"median":-11.326512,"eighty":-4.691605,"marketCap":2027250394},{"date":"2023-12-08","current":-19.523899,"twenty":-20.469266,"median":-11.343011,"eighty":-4.703566,"marketCap":2015003094},{"date":"2023-12-15","current":-21.372612,"twenty":-20.485729,"median":-11.403123,"eighty":-4.710056,"marketCap":2205803131},{"date":"2023-12-22","current":-21.178997,"twenty":-20.539127,"median":-11.433755,"eighty":-4.725299,"marketCap":2185820695},{"date":"2023-12-29","current":-22.378161,"twenty":-20.560916,"median":-11.460738,"eighty":-4.752445,"marketCap":2309582881},{"date":"2024-01-05","current":-21.616192,"twenty":-20.635863,"median":-11.478255,"eighty":-4.774704,"marketCap":2230942325},{"date":"2024-01-12","current":-24.694637,"twenty":-20.763319,"median":-11.573996,"eighty":-4.807425,"marketCap":2548659433},{"date":"2024-01-19","current":-28.378521,"twenty":-20.874895,"median":-11.672989,"eighty":-4.871722,"marketCap":2928862002},{"date":"2024-01-26","current":-30.347082,"twenty":-20.925237,"median":-11.754932,"eighty":-4.928537,"marketCap":3132031295},{"date":"2024-02-02","current":-31.796601,"twenty":-20.995241,"median":-11.84903,"eighty":-5.022175,"marketCap":3281631848},{"date":"2024-02-09","current":-31.989395,"twenty":-21.094154,"median":-11.907283,"eighty":-5.032659,"marketCap":3301529459},{"date":"2024-02-16","current":-33.160435,"twenty":-21.134993,"median":-12.008876,"eighty":-5.086047,"marketCap":3422389019},{"date":"2024-02-23","current":-29.405371,"twenty":-21.18143,"median":-12.106086,"eighty":-5.094177,"marketCap":3321660162},{"date":"2024-03-01","current":-29.504379,"twenty":-21.252364,"median":-12.196466,"eighty":-5.100274,"marketCap":3332844203},{"date":"2024-03-08","current":-29.854208,"twenty":-21.362618,"median":-12.275201,"eighty":-5.134457,"marketCap":3372361147},{"date":"2024-03-15","current":-29.570385,"twenty":-21.39159,"median":-12.312278,"eighty":-5.167912,"marketCap":3340300230},{"date":"2024-03-22","current":-30.118229,"twenty":-21.456111,"median":-12.35282,"eighty":-5.193104,"marketCap":3402185256},{"date":"2024-03-28","current":-28.586905,"twenty":-21.586005,"median":-12.411316,"eighty":-5.211962,"marketCap":3229205423},{"date":"2024-04-05","current":-27.326204,"twenty":-21.698819,"median":-12.663882,"eighty":-5.224529,"marketCap":3086795302},{"date":"2024-04-12","current":-28.685913,"twenty":-21.801282,"median":-12.695915,"eighty":-5.23565,"marketCap":3240389464},{"date":"2024-04-19","current":-24.831203,"twenty":-21.90599,"median":-12.746573,"eighty":-5.260951,"marketCap":2804957470},{"date":"2024-04-26","current":-25.561122,"twenty":-21.970513,"median":-12.778856,"eighty":-5.33492,"marketCap":2887409933},{"date":"2024-05-03","current":-27.460667,"twenty":-22.002271,"median":-12.852662,"eighty":-5.443511,"marketCap":3101984415},{"date":"2024-05-10","current":-23.864016,"twenty":-22.106629,"median":-13.01501,"eighty":-5.504053,"marketCap":3075904561},{"date":"2024-05-17","current":-24.386628,"twenty":-22.316456,"median":-13.122963,"eighty":-5.514677,"marketCap":3143265660},{"date":"2024-05-24","current":-22.578036,"twenty":-22.408348,"median":-13.19089,"eighty":-5.517064,"marketCap":2910150846},{"date":"2024-05-31","current":-21.016071,"twenty":-22.408348,"median":-13.405255,"eighty":-5.517064,"marketCap":2708824416},{"date":"2024-06-07","current":-23.270938,"twenty":-22.480222,"median":-13.492753,"eighty":-5.517064,"marketCap":2999461067},{"date":"2024-06-14","current":-22.859895,"twenty":-22.573944,"median":-13.658594,"eighty":-5.526194,"marketCap":2946480428},{"date":"2024-06-21","current":-21.297929,"twenty":-22.578036,"median":-13.849482,"eighty":-5.550065,"marketCap":2745153997},{"date":"2024-06-28","current":-20.18224,"twenty":-22.604654,"median":-14.065248,"eighty":-5.737455,"marketCap":2601349404},{"date":"2024-07-05","current":-19.548058,"twenty":-22.604654,"median":-14.207014,"eighty":-5.875249,"marketCap":2519607846},{"date":"2024-07-12","current":-25.833502,"twenty":-22.663386,"median":-14.56294,"eighty":-6.158782,"marketCap":3329757590},{"date":"2024-07-15","current":-26.081274,"twenty":-22.683944,"median":-14.611833,"eighty":-6.204137,"marketCap":3361693680},{"date":"2024-08-02","current":-27.685273,"twenty":-22.729538,"median":-15.101131,"eighty":-7.080248,"marketCap":3568437841},{"date":"2024-08-09","current":-20.650678,"twenty":-22.791755,"median":-15.174216,"eighty":-7.173892,"marketCap":3174814544},{"date":"2024-08-16","current":-20.941919,"twenty":-22.791755,"median":-15.356928,"eighty":-7.243187,"marketCap":3219589736},{"date":"2024-08-23","current":-21.062812,"twenty":-22.791755,"median":-15.420877,"eighty":-7.280035,"marketCap":3238175665},{"date":"2024-08-30","current":-21.524403,"twenty":-22.791755,"median":-15.493961,"eighty":-7.318659,"marketCap":3309140119},{"date":"2024-09-06","current":-20.53528,"twenty":-22.791755,"median":-15.548775,"eighty":-7.330832,"marketCap":3157073430},{"date":"2024-09-13","current":-19.842894,"twenty":-22.791755,"median":-15.658402,"eighty":-7.386643,"marketCap":3050626748},{"date":"2024-09-20","current":-19.386799,"twenty":-22.791755,"median":-15.731487,"eighty":-7.41883,"marketCap":2980507108},{"date":"2024-09-27","current":-16.76013,"twenty":-22.791755,"median":-15.7863,"eighty":-7.470507,"marketCap":2576685567},{"date":"2024-10-04","current":-16.073239,"twenty":-22.791755,"median":-15.877656,"eighty":-7.496684,"marketCap":2471083699},{"date":"2024-10-11","current":-16.595276,"twenty":-22.791755,"median":-15.923334,"eighty":-7.600254,"marketCap":2551341118},{"date":"2024-10-18","current":-16.864537,"twenty":-22.791755,"median":-15.959877,"eighty":-7.641123,"marketCap":2592737050},{"date":"2024-10-25","current":-16.045763,"twenty":-22.791755,"median":-16.042097,"eighty":-7.711567,"marketCap":2466859624},{"date":"2024-10-31","current":-16.188637,"twenty":-22.791755,"median":-16.087775,"eighty":-7.784511,"marketCap":2488824813},{"date":"2024-11-08","current":-14.552491,"twenty":-22.793308,"median":-16.087775,"eighty":-7.860776,"marketCap":2592089652},{"date":"2024-11-15","current":-14.300163,"twenty":-22.793308,"median":-16.087775,"eighty":-7.961667,"marketCap":2547145116},{"date":"2024-11-22","current":-12.907511,"twenty":-22.793308,"median":-16.087775,"eighty":-8.046396,"marketCap":2299085853},{"date":"2024-11-29","current":-13.276297,"twenty":-22.793308,"median":-16.087775,"eighty":-8.103024,"marketCap":2364774020},{"date":"2024-12-06","current":-12.795905,"twenty":-22.793308,"median":-16.087775,"eighty":-8.12743,"marketCap":2279206539},{"date":"2024-12-13","current":-12.50961,"twenty":-22.793308,"median":-16.087775,"eighty":-8.178203,"marketCap":2228211778},{"date":"2024-12-20","current":-12.029218,"twenty":-22.793308,"median":-16.087775,"eighty":-8.232893,"marketCap":2142644297},{"date":"2024-12-27","current":-12.54843,"twenty":-22.793308,"median":-16.087775,"eighty":-8.272654,"marketCap":2235126322},{"date":"2025-01-03","current":-12.208758,"twenty":-22.793308,"median":-16.087775,"eighty":-8.306032,"marketCap":2174624062},{"date":"2025-01-10","current":-12.058333,"twenty":-22.79486,"median":-16.087775,"eighty":-8.349042,"marketCap":2147830205},{"date":"2025-01-17","current":-11.024761,"twenty":-22.79486,"median":-16.087775,"eighty":-8.387198,"marketCap":1963730473},{"date":"2025-01-24","current":-11.301351,"twenty":-22.79486,"median":-16.087775,"eighty":-8.421336,"marketCap":2012996598},{"date":"2025-01-31","current":-11.587645,"twenty":-22.79486,"median":-16.087775,"eighty":-8.512709,"marketCap":2063991360},{"date":"2025-02-07","current":-11.626465,"twenty":-22.79486,"median":-16.087775,"eighty":-8.629402,"marketCap":2070905904},{"date":"2025-02-14","current":-6.537248,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1794324147},{"date":"2025-02-21","current":-6.930226,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1902187506},{"date":"2025-02-28","current":-6.455028,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1771756793},{"date":"2025-03-07","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-03-14","current":-6.046805,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1659708933},{"date":"2025-03-21","current":-5.880964,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1614189490},{"date":"2025-03-28","current":-5.558851,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1525776725},{"date":"2025-04-04","current":-4.965652,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1362957177},{"date":"2025-04-11","current":-5.029437,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1380464656},{"date":"2025-04-17","current":-5.160196,"twenty":-22.79486,"median":-16.087775,"eighty":-8.645873,"marketCap":1416354986},{"date":"2025-04-25","current":-6.081887,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1669338046},{"date":"2025-05-02","current":-6.528381,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1791890393},{"date":"2025-05-09","current":-5.185048,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1592240087},{"date":"2025-05-16","current":-4.936919,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1516043779},{"date":"2025-05-23","current":-5.327651,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1636031068},{"date":"2025-05-30","current":-5.718383,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1756018358},{"date":"2025-06-06","current":-6.01785,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1847979419},{"date":"2025-06-13","current":-6.354393,"twenty":-22.796413,"median":-16.087775,"eighty":-8.650599,"marketCap":1951326135},{"date":"2025-06-20","current":-6.234607,"twenty":-22.797965,"median":-16.087775,"eighty":-8.644345,"marketCap":1914541711},{"date":"2025-06-27","current":-6.357245,"twenty":-22.797965,"median":-16.087775,"eighty":-8.623821,"marketCap":1952201955},{"date":"2025-07-03","current":-6.303056,"twenty":-22.797965,"median":-16.087775,"eighty":-8.578381,"marketCap":1935561382},{"date":"2025-07-11","current":-6.5027,"twenty":-22.797965,"median":-16.087775,"eighty":-8.537547,"marketCap":1996868756},{"date":"2025-07-18","current":-6.300204,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1934685562},{"date":"2025-07-25","current":-7.081669,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2174660141},{"date":"2025-08-01","current":-6.94477,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2132620799},{"date":"2025-08-08","current":-5.919479,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":1964095003},{"date":"2025-08-15","current":-6.437202,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2135876627},{"date":"2025-08-22","current":-6.50588,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2158663986},{"date":"2025-08-29","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-05","current":-6.822853,"twenty":-22.800061,"median":-16.094245,"eighty":-8.503193,"marketCap":2263836409},{"date":"2025-09-12","current":-6.585123,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2184957091},{"date":"2025-09-19","current":-6.92587,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2298017446},{"date":"2025-09-26","current":-6.785873,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2251566293},{"date":"2025-10-03","current":-7.184731,"twenty":-22.797965,"median":-16.087775,"eighty":-8.47506,"marketCap":2383908259},{"date":"2025-10-10","current":-7.076432,"twenty":-22.797965,"median":-16.087775,"eighty":-8.426063,"marketCap":2347974347},{"date":"2025-10-17","current":-7.314162,"twenty":-22.797965,"median":-16.087775,"eighty":-8.383627,"marketCap":2426853665},{"date":"2025-10-24","current":-7.506988,"twenty":-22.797965,"median":-16.087775,"eighty":-8.36786,"marketCap":2490833556},{"date":"2025-10-31","current":-8.346967,"twenty":-22.797965,"median":-16.087775,"eighty":-8.39891,"marketCap":2769540477},{"date":"2025-11-07","current":-16.280273,"twenty":-22.797965,"median":-16.115182,"eighty":-8.446927,"marketCap":2616842278},{"date":"2025-11-14","current":-17.354717,"twenty":-22.797965,"median":-16.176647,"eighty":-8.45396,"marketCap":2789545102},{"date":"2025-11-21","current":-18.085556,"twenty":-22.797965,"median":-16.210617,"eighty":-8.45396,"marketCap":2907018089},{"date":"2025-11-28","current":-19.427247,"twenty":-22.797965,"median":-16.280273,"eighty":-8.45396,"marketCap":3122677452},{"date":"2025-12-05","current":-19.639954,"twenty":-22.797965,"median":-16.315109,"eighty":-8.45396,"marketCap":3156867352},{"date":"2025-12-12","current":-18.303718,"twenty":-22.797965,"median":-16.365703,"eighty":-8.45396,"marketCap":2942084652},{"date":"2025-12-19","current":-18.140097,"twenty":-22.797965,"median":-16.416656,"eighty":-8.45396,"marketCap":2915784730},{"date":"2025-12-26","current":-19.459971,"twenty":-22.797965,"median":-16.47147,"eighty":-8.45396,"marketCap":3127937437},{"date":"2026-01-02","current":-18.854574,"twenty":-22.797965,"median":-16.52495,"eighty":-8.45396,"marketCap":3030627724},{"date":"2026-01-09","current":-19.869024,"twenty":-22.797965,"median":-16.599368,"eighty":-8.45396,"marketCap":3193687243},{"date":"2026-01-16","current":-19.667225,"twenty":-22.797965,"median":-16.654182,"eighty":-8.45396,"marketCap":3161250672},{"date":"2026-01-23","current":-19.743581,"twenty":-22.797965,"median":-16.776759,"eighty":-8.45396,"marketCap":3173523969},{"date":"2026-01-30","current":-17.992838,"twenty":-22.797965,"median":-16.864537,"eighty":-8.45396,"marketCap":2892114799},{"date":"2026-02-06","current":-17.327447,"twenty":-22.797965,"median":-16.944631,"eighty":-8.45396,"marketCap":2785161782},{"date":"2026-02-13","current":-17.191096,"twenty":-22.797965,"median":-16.997091,"eighty":-8.45396,"marketCap":2763245180},{"date":"2026-02-20","current":-25.410135,"twenty":-22.829497,"median":-17.067857,"eighty":-8.45396,"marketCap":2889081488},{"date":"2026-02-27","current":-24.63779,"twenty":-22.859895,"median":-17.238205,"eighty":-8.45396,"marketCap":2801267461},{"date":"2026-03-06","current":-25.510539,"twenty":-22.975694,"median":-17.398349,"eighty":-8.45396,"marketCap":2900497311},{"date":"2026-03-13","current":-25.356071,"twenty":-23.059318,"median":-17.427264,"eighty":-8.45396,"marketCap":2882934506},{"date":"2026-03-20","current":-25.178431,"twenty":-23.145422,"median":-17.532711,"eighty":-8.45396,"marketCap":2862737280},{"date":"2026-03-27","current":-24.784536,"twenty":-23.270938,"median":-17.545608,"eighty":-8.45396,"marketCap":2817952126},{"date":"2026-04-02","current":-25.08575,"twenty":-23.407723,"median":-17.545608,"eighty":-8.45396,"marketCap":2852199596},{"date":"2026-04-10","current":-23.94268,"twenty":-23.579678,"median":-17.545608,"eighty":-8.45396,"marketCap":2722234837},{"date":"2026-04-17","current":-25.10892,"twenty":-23.717857,"median":-17.696952,"eighty":-8.45396,"marketCap":2854834017},{"date":"2026-04-24","current":-23.710977,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2695890628},{"date":"2026-05-01","current":-22.475225,"twenty":-23.781807,"median":-17.753729,"eighty":-8.45396,"marketCap":2555388185},{"date":"2026-05-08","current":-17.715337,"twenty":-23.781807,"median":-17.742113,"eighty":-8.45396,"marketCap":2481192380},{"date":"2026-05-15","current":-18.091725,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-05-22","current":-18.530845,"twenty":-23.781807,"median":-17.665967,"eighty":-8.45396,"marketCap":2595411576},{"date":"2026-05-29","current":-18.405382,"twenty":-23.784228,"median":-17.665782,"eighty":-8.452553,"marketCap":2577839392},{"date":"2026-06-05","current":-18.330104,"twenty":-23.781807,"median":-17.665596,"eighty":-8.45396,"marketCap":2567296082},{"date":"2026-06-12","current":-18.091725,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2533908932},{"date":"2026-06-18","current":-19.609824,"twenty":-23.781807,"median":-17.640059,"eighty":-8.45396,"marketCap":2746532359},{"date":"2026-06-26","current":-22.765212,"twenty":-23.784228,"median":-17.624377,"eighty":-8.452553,"marketCap":3188472786},{"date":"2026-07-02","current":-24.555061,"twenty":-23.887071,"median":-17.624377,"eighty":-8.452553,"marketCap":3439157354},{"date":"2026-07-10","current":-25.308617,"twenty":-24.08363,"median":-17.624377,"eighty":-8.452553,"marketCap":3544699645},{"date":"2026-07-17","current":-24.39213,"twenty":-24.253162,"median":-17.624377,"eighty":-8.452553,"marketCap":3416337399},{"date":"2026-07-24","current":-24.595794,"twenty":-24.196085,"median":-17.624377,"eighty":-8.452553,"marketCap":3444862343},{"date":"2026-07-31","current":-24.711204,"twenty":-24.166881,"median":-17.608694,"eighty":-8.451147,"marketCap":3461026478},{"date":"2026-08-07","current":-19.97931,"twenty":-24.08533,"median":-17.608694,"eighty":-8.451147,"marketCap":3496778900},{"date":"2026-08-14","current":-20.221885,"twenty":-23.924144,"median":-17.608694,"eighty":-8.451147,"marketCap":3539234273},{"date":"2026-08-21","current":-21.561557,"twenty":-23.777689,"median":-17.608694,"eighty":-8.451147,"marketCap":3773703719},{"date":"2026-08-28","current":-23.02803,"twenty":-23.690057,"median":-17.608694,"eighty":-8.451147,"marketCap":4030365746},{"date":"2026-08-31","current":-22.112863,"twenty":-23.659867,"median":-17.608694,"eighty":-8.451147,"marketCap":3870193203}],"updateTime":1788292018057},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDYA\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627110431","title":"Ideaya Biosciences, Servier announce topline results from OptimUM-02 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627110431","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627110431?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:19","pubTimestamp":1776075548,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences (IDYA) and Servier announced topline results from their Phase 2/3 registrational trial, OptimUM-02, evaluating darovasertib in c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-servier-announce-topline-results-from-optimum-02-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ideaya-biosciences-servier-announce-topline-results-from-optimum-02-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131239826","title":"U.S. Stocks to Watch: Goldman Sachs, SanDisk, Exxon Mobil, Nvidia, Ideaya, and More","url":"https://stock-news.laohu8.com/highlight/detail?id=1131239826","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131239826?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:10","pubTimestamp":1776075008,"startTime":"0","endTime":"0","summary":"Stock futures were falling Monday after peace talks between the U.S. and Iran faltered and President Donald Trump threatened to blockade the Strait of Hormuz.These stocks were making moves in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","SNDK","XOM","IDYA","GS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431813","title":"Ideaya eye cancer drug meets main goal of mid-to-late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431813","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431813?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:04","pubTimestamp":1776074695,"startTime":"0","endTime":"0","summary":"Ideaya eye cancer drug meets main goal of mid-to-late-stage trialApril 13  - Ideaya Biosciences IDYA.O said on Monday its drug for a type of eye cancer met the main goal of a mid-to-late-stage trial, after showing improvement in patients' survival without progression of the disease.  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627431864","title":"IDEAYA says darovasertib-crizotinib trial cuts progression risk 58% in metastatic uveal melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627431864","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627431864?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:01","pubTimestamp":1776074490,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences reported positive topline results from OptimUM-02, a Phase 2/3 registrational trial of darovasertib with crizotinib in first-line HLA-A02:01-negative metastatic uveal melanoma.Trial met primary endpoint, showing patients on combination therapy stayed progression-free longer than investigator-choice immunotherapy.Study also showed higher tumor response rates for combination therapy, including complete responses, versus standard immunotherapy options.Overall survival data remain immature, though results showed an early favorable trend for combination therapy.Full trial data will be presented at a major medical conference in 2026; IDEAYA targets an FDA NDA submission in H2 2026 to support a US accelerated approval filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL5ShScL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439719","title":"IDEAYA Biosciences Shares Gain 18% Premarket Ahead of Data Release for Its Experimental Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439719","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439719?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074402,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nL4N40W0LU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627748439","title":"IDEAYA Biosciences Inc - Trial Met Primary Endpoint Showing Statistically Significant Improvement in Median Pfs by Bicr","url":"https://stock-news.laohu8.com/highlight/detail?id=2627748439","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627748439?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439714","title":"IDEAYA Biosciences Inc - Nda Submission Planned for Second Half of 2026 to Support U.S. Accelerated Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439714","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439714?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627439710","title":"IDEAYA Biosciences and Servier Announce Positive Topline Results From Phase 2/3 Registrational Trial (Optimum-02) of Darovasertib in Combination With Crizotinib in First-Line Hla-a*02:01-Negative Metastatic Uveal Melanoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2627439710","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627439710?lang=en_us&edition=fundamental","pubTime":"2026-04-13 18:00","pubTimestamp":1776074401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nTUA2G2T5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627398484","title":"Why IDEAYA Biosciences Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2627398484","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627398484?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:27","pubTimestamp":1776072420,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences shares (NASDAQ: IDYA) jumped 18% in pre-market trading after announcing topline results from ongoing Phase 2/3 trial.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/04/13/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/04/13/Section-Of-A-Financial-Newspaper-Titled-.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/26/04/51773369/why-ideaya-biosciences-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/26/04/51773369/why-ideaya-biosciences-shares-are-trading-higher-by-18-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627436996","title":"Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (IDYA) and Certara (CERT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627436996","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627436996?lang=en_us&edition=fundamental","pubTime":"2026-04-13 17:10","pubTimestamp":1776071429,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and Certara (CERT) with bu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ideaya-biosciences-idya-and-certara-cert-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","HCSG","XLV","BK4139","BK4167","LABU","XBI","BK4585","LU0029874061.USD","BK4581","LU0128526141.USD","CERT","IDYA","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626145582","title":"Ideaya Biosciences Shares Gain Ahead of Trial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2626145582","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626145582?lang=en_us&edition=fundamental","pubTime":"2026-04-11 05:52","pubTimestamp":1775857920,"startTime":"0","endTime":"0","summary":"Ideaya Biosciences shares rose after the company said it plans to release results of its melanoma treatment trial.The stock gained 18% to $36 in after-hours trading Friday. Through the close, shares were down 12%.The oncology company said it plans to disclose on Monday topline results from its ongoing trial with Servier.The trial is a Phase 2/3 registrational study evaluating darovasertib in combination with crizotinib in patients with a certain type of melanoma.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626148803","title":"BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626148803","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626148803?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:19","pubTimestamp":1775852354,"startTime":"0","endTime":"0","summary":"BRIEF-Ideaya Biosciences To Announce Topline Results From Phase 2/3 Optimum-02 Trial In Metastatic Uveal Melanoma On Monday, April 13, 2026April 10 (Reuters) - IDEAYA Biosciences Inc IDYA.O:IDEAYA BIO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA9ZCH3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626111047","title":"IDEAYA to report topline OptimUM-02 darovasertib-crizotinib trial results April 13","url":"https://stock-news.laohu8.com/highlight/detail?id=2626111047","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626111047?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:06","pubTimestamp":1775851564,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences scheduled a pre-market press release and investor call for April 13, 2026 to disclose topline results from Phase 2/3 OptimUM-02.Results have not yet been presented; disclosure is planned for the April 13 event.OptimUM-02 evaluates darovasertib combined with crizotinib in first-line HLA-A2-negative metastatic uveal melanoma.Update is expected to clarify whether the regimen shows sufficient clinical benefit to support a registrational path in this patient group.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL8G2D9C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626611049","title":"IDEAYA Biosciences to Announce Topline Results From Phase 2/3 Optimum-02 Trial in Metastatic Uveal Melanoma on Monday, April 13, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626611049","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626611049?lang=en_us&edition=fundamental","pubTime":"2026-04-11 04:05","pubTimestamp":1775851500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA9ZCH3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626231134","title":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman","url":"https://stock-news.laohu8.com/highlight/detail?id=2626231134","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626231134?lang=en_us&edition=fundamental","pubTime":"2026-04-10 01:51","pubTimestamp":1775757106,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-FormanWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call new","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL6N40S0MV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CORD","HRL","TSLG","APLD","CRSH","CRWU","TEMT","RELL","MRVU","CG","CRWG","MVLL","ANVS","MRVL","TSLO","TSLQ","VNDA","TSLR","STAA","NUAI","TSLA","CAT","TSLS","TEM","BLSX","BLSH","FDX","ADSK","SMPL","GLMD","STZ","NRGV","WW","TSLL","KYMR","NOC","NOW","CRWV","BLSG","CCCC","TSL","GDRX","TSLP","FBRX","TSLI","AMZN","OXY","AZYY","WSR","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626183051","title":"Ideaya Biosciences Inc - Enters Clinical Collaboration Agreement With Astrazeneca On April 8, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626183051","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626183051?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:22","pubTimestamp":1775730160,"startTime":"0","endTime":"0","summary":"April 9 (Reuters) - IDEAYA Biosciences Inc ::*IDEAYA BIOSCIENCES INC - ENTERS CLINICAL COLLABORATION AGREEMENT WITH ASTRAZENECA ON APRIL 8, 2026 - SEC FILING*IDEAYA BIOSCIENCES INC - AGREEMENT TO EVAL","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nRSD5XTtDX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0211326755.USD","LU0857590862.USD","IE00BJT1NW94.SGD","LU1019634622.SGD","LU1153584641.USD","03165","LU2089984988.USD","LU1496350171.SGD","LU1019632923.USD","LU0882574055.USD","LU0158827948.USD","LU1301847155.USD","LU1267930813.SGD","LU0963555726.SGD","SGXZ57979304.SGD","LU1923622614.USD","LU0949170772.SGD","LU1989771016.USD","LU0889566641.SGD","LU1291159041.SGD","LU0171293334.USD","BK4139","LU2112291526.USD","LU2539964713.USD","LU1880407132.USD","LU1084165304.USD","LU0784385840.USD","LU0203347892.USD","AZN.UK","LU1061106388.HKD","LU0949170426.SGD","LU2089284900.SGD","SG9999001176.USD","LU1015430645.USD","IDYA","LU0976567544.SGD","LU1481600234.SGD","IE00B2B36J28.USD","LU0964806797.USD","SG9999001176.SGD","LU0823416689.USD","LU1323610961.USD","LU0211327993.USD","LU1261432733.SGD","LU0887340254.USD","LU0211328371.USD","LU2023251221.USD","LU0310799852.SGD","LU1880407215.USD","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626636183","title":"IDEAYA, AstraZeneca partner to test IDE849 with Imfinzi in small cell lung cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2626636183","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626636183?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:05","pubTimestamp":1775729158,"startTime":"0","endTime":"0","summary":"IDEAYA Biosciences entered clinical collaboration agreement with AstraZeneca on April 8, 2026 to test IDE849 with AstraZeneca’s Imfinzi  in extensive-stage small cell lung cancer.Collaboration supports IDEAYA’s ongoing global Phase 1 program for IDE849 across DLL3-upregulated solid tumors, including small cell lung cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IDEAYA Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 09, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nNDL9lzHCr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310800379.SGD","LU0784385170.HKD","LU0211326755.USD","LU2125909593.SGD","LU0857590862.USD","03165","LU2089984988.USD","LU1496350171.SGD","LU0882574055.USD","LU1023059063.AUD","LU1301847155.USD","LU0889565080.SGD","LU0345777659.USD","LU0920783379.SGD","LU1170363599.USD","LU1923622614.USD","LU0969580561.USD","LU0058720904.USD","LU0289739699.SGD","LU0949170772.SGD","BK5011","LU1078025761.USD","LU1291159041.SGD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU1983299246.USD","LU2125909247.SGD","LU0997586432.USD","LU0047473722.EUR","LU1003077747.HKD","LU0784385840.USD","LU0203347892.USD","AZN.UK","LU2089284900.SGD","IE00B4R5TH58.HKD","LU2133065610.SGD","LU2468319806.SGD","LU2089283258.USD","LU1015430645.USD","IDYA","LU0976567544.SGD","LU1814569148.SGD","LU2293690249.USD","LU0823399737.USD","LU0211327993.USD","LU0920840948.USD","LU0553294199.USD","LU2293690082.USD","LU0887340254.USD","LU2091194634.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626529183","title":"IDEAYA Biosciences Inc - Co to Sponsor Study; AstraZeneca to Supply Imfinzi - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626529183","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626529183?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:05","pubTimestamp":1775729119,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40R1J1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IDYA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626183501","title":"IDEAYA Biosciences Inc - Agreement to Evaluate Ide849 With Imfinzi in Extensive-Stage Small Cell Lung Cancer - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626183501","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626183501?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:05","pubTimestamp":1775729119,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40R1J1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626018350","title":"IDEAYA Biosciences Inc - Advancing Global Phase 1 Trial for Ide849 in Dll3 Upregulated Solid Tumors - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2626018350","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626018350?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:05","pubTimestamp":1775729119,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40R1J1:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IDYA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":199,"code":"91000000","status":"200"}]}}